In Depth 27 Nov 2024Charcot–Marie–Tooth disease: what’s going on in the clinical field? In this article, we take a look at the various treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease. November 27, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Nov 2024Sleep apnea: biotechs snore points in the therapeutic space Therapeutic strides in biotech are proving to help address different stages of the sleep apnea. November 13, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2024Six exosome therapy companies driving development in the field Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases. November 12, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2024Cystic fibrosis: Five biotechs breathing life into the therapeutic space In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease. November 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024GPCR therapies: Eight promising biotechs hacking the cell signaling pathway In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines. October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Oct 2024Promising cure for COPD: Is a breakthrough treatment within reach? Find out whether a promising cure for COPD is within reach, after recent advancements in treatments and research around the disease. October 9, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2024Spinal cord injury: Are we getting closer to a treatment? Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition. October 7, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Oct 2024Six biotechs driving progress in Duchenne muscular dystrophy In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. October 3, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 26 Sep 2024The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation. September 26, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 20 Sep 2024Mitigating hot flashes: new therapies for menopause on the rise New therapies could address menopause symptoms, a field in which many treatment gaps still exist. September 20, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024Mitochondrial disease treatments: is a breakthrough on the horizon? Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases. September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 10 Sep 2024Accelerating the path to clinical filing applications with rapid toxicology material delivery Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials. September 10, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email